122 related articles for article (PubMed ID: 24038238)
1. Association between polymorphism of beta3-adrenoceptor gene and overactive bladder.
Honda K; Yamaguchi O; Nomiya M; Shishido K; Ishibashi K; Takahashi N; Aikawa K
Neurourol Urodyn; 2014 Apr; 33(4):400-2. PubMed ID: 24038238
[TBL] [Abstract][Full Text] [Related]
2. Association between polymorphism of β3-adrenoceptor gene and overactive bladder: a meta-analysis.
Qu HC; Zhang W; Liu YL; Wang P
Genet Mol Res; 2015 Mar; 14(1):2495-501. PubMed ID: 25867395
[TBL] [Abstract][Full Text] [Related]
3. Association between the Trp64Arg polymorphism of the ADRB3 gene and overactive bladder.
Çırakoğlu A; Fejzullahu A; Benli E; Yuce A; Ayyıldız A; Aynacıoğlu AŞ
Neurourol Urodyn; 2021 Sep; 40(7):1780-1785. PubMed ID: 34260097
[TBL] [Abstract][Full Text] [Related]
4. The relationship between the Trp 64 Arg polymorphism of the beta 3-adrenoceptor gene and idiopathic overactive bladder.
Ferreira CE; Fonseca AM; Silva ID; Girão MJ; Sartori MG; Castro RA
Am J Obstet Gynecol; 2011 Jul; 205(1):82.e10-4. PubMed ID: 21529759
[TBL] [Abstract][Full Text] [Related]
5. Are β
Michel MC
Neurourol Urodyn; 2023 Jan; 42(1):33-39. PubMed ID: 36321795
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of Trp64Arg in beta3-adrenergic receptor gene among Bolivian people in rural areas at high and low altitudes.
Karasaki Y; Kashiwazaki H
Ann Clin Biochem; 2004 Jan; 41(Pt 1):57-60. PubMed ID: 14713387
[TBL] [Abstract][Full Text] [Related]
7. Beta3-adrenoceptors in urinary bladder.
Yamaguchi O; Chapple CR
Neurourol Urodyn; 2007; 26(6):752-6. PubMed ID: 17600372
[TBL] [Abstract][Full Text] [Related]
8. A multicenter, double-blind, randomized, placebo-controlled trial of the β3-adrenoceptor agonist solabegron for overactive bladder.
Ohlstein EH; von Keitz A; Michel MC
Eur Urol; 2012 Nov; 62(5):834-40. PubMed ID: 22695239
[TBL] [Abstract][Full Text] [Related]
9. The Trp64Arg polymorphism of the beta3-adrenergic receptor gene is associated with increased small dense low-density lipoprotein in a rural Japanese population: the Mima study.
Tsuzaki K; Kotani K; Fujiwara S; Sano Y; Matsuoka Y; Domichi M; Hamada T; Shimatsu A; Sakane N
Metabolism; 2007 Dec; 56(12):1689-93. PubMed ID: 17998022
[TBL] [Abstract][Full Text] [Related]
10. Role of β-3 adrenergic receptor polymorphism in overactive bladder.
Meekins AR; Murphy SK; Grenier C; Huang Z; Bradley MS; Amundsen CL; Wu J; Siddiqui NY
Neurourol Urodyn; 2019 Jun; 38(5):1261-1265. PubMed ID: 31009102
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of insulin receptor substrate 1 and beta3-adrenergic receptor genes in gestational diabetes and normal pregnancy.
Fallucca F; Dalfrà MG; Sciullo E; Masin M; Buongiorno AM; Napoli A; Fedele D; Lapolla A
Metabolism; 2006 Nov; 55(11):1451-6. PubMed ID: 17046546
[TBL] [Abstract][Full Text] [Related]
12. Tryptophan 64 --> arginine polymorphism of beta-3-adrenergic receptor in Chilean women with polycystic ovary syndrome.
Pérez-Bravo F; Echiburú B; Maliqueo M; Santos JL; Sir-Petermann T
Clin Endocrinol (Oxf); 2005 Feb; 62(2):126-31. PubMed ID: 15670186
[TBL] [Abstract][Full Text] [Related]
13. The genetic polymorphisms of beta3-adrenergic receptor (AR) Trp64Arg and beta2-AR Gln27Glu are associated with obesity in Chinese male hypertensive patients.
Mo W; Zhang GG; Yang TL; Dai XP; Li HH; Zeng H; Liu J; Tan YM; Zhou HH; Liu ZQ
Clin Chem Lab Med; 2007; 45(4):493-8. PubMed ID: 17439327
[TBL] [Abstract][Full Text] [Related]
14. An association between the Trp64Arg polymorphism in the beta3-adrenergic receptor gene and endometrial cancer and obesity.
Babol K; Przybylowska K; Lukaszek M; Pertynski T; Blasiak J
J Exp Clin Cancer Res; 2004 Dec; 23(4):669-74. PubMed ID: 15743038
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder.
Ginsberg D; Schneider T; Kelleher C; Van Kerrebroeck P; Swift S; Creanga D; Martire DL
BJU Int; 2013 Aug; 112(3):373-85. PubMed ID: 23826844
[TBL] [Abstract][Full Text] [Related]
16. The promise of beta3-adrenoceptor agonists to treat the overactive bladder.
Furuta A; Thomas CA; Higaki M; Chancellor MB; Yoshimura N; Yamaguchi O
Urol Clin North Am; 2006 Nov; 33(4):539-43, x. PubMed ID: 17011390
[TBL] [Abstract][Full Text] [Related]
17. Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms.
Kaplan SA; Roehrborn CG; Gong J; Sun F; Guan Z
BJU Int; 2012 Jun; 109(12):1831-40. PubMed ID: 21966995
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum leptin in patients with coronary artery disease: no association with the Trp64Arg polymorphism of the beta3-adrenergic receptor.
Stangl K; Cascorbi I; Laule M; Stangl V; Vogt M; Ziemer S; Roots I; Wernecke K; Baumann G; Hauner H
Int J Obes Relat Metab Disord; 2000 Mar; 24(3):369-75. PubMed ID: 10757633
[TBL] [Abstract][Full Text] [Related]
19. Relation of ADRB3, GEF, ROCK2 gene polymorphisms to clinical findings in overactive bladder.
Fırat E; Aybek Z; Akgün Ş; Küçüker K; Akça H; Aybek H
World J Urol; 2020 Oct; 38(10):2571-2575. PubMed ID: 31802204
[TBL] [Abstract][Full Text] [Related]
20. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
